I think that most people are waiting for the next step re: US market penetration - AGR2 & OvPlex patents; distribution partner; FDA clearance; & the peer reviewed publication of trial results.
Then eventually followed by a 'revised' OvPlex roll-out with AGR2 included in the panel...
It's this trial result that's really important for HTX methinks - but I reckon that we wont see this announced until their IP is fully protected (i.e. once both patents are approved).
Add to My Watchlist
What is My Watchlist?